Wenger Vieli advised Avelo on the deal. Avelo AG, a Swiss breath diagnostics company with a mission to make every breath count for better infectious disease...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised NLS Pharmaceutics on the deal. NLS Pharmaceutics Ltd., a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised the shareholders of MENU Technologies Ltd on the deal. MENU has become part of the NYSE listed PAR Technology Corp. group. The MENU...
You must be a Standard 1 Year member to access this content.
Baker McKenzie Switzerland advised Datwyler on the transaction. Wenger Vieli advised the shareholders of CTsystems. Datwyler executed the acquisition of Swiss startup company CTsystems AG. Datwyler...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised the French impact fund STOA Infra & Energy on the deal. The French impact fund STOA Infra & Energy led the Series B financing...
You must be a Standard 1 Year member to access this content.
Dentons, Wenger Vieli, Setterwals, Binder Grösswang Rechtsanwälte and HPP Attorneys have advised Beretta Holding S.A. on the deal. Baker McKenzie assisted RUAG International Holding on the...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised Xeltis AG on the deal. The Chinese company Grand Pharmaceutical Group Ltd (0512.HK) has committed to invest €15 million in equity and license...
You must be a Standard 1 Year member to access this content.
Schoenherr, Loloci & Partners, Pinsent Masons LLP and Wenger Vieli AG advised Kontron AG on the deal, Baker & McKenzie advised VINCI Energies. Kontron AG (formerly...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised Stableton on the deal, while DLA Piper advised C3 EOS VC I Fund. Stableton, a Swiss Fintech platform for Alternative Investments, closed their CHF...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised PIPRA on the deal. The Zurich based Startup PIPRA has developed an AI-based pre-operative test to assess a patient’s risk of suffering from...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised Nexenic on the deal. Nexenic, a Winterthur-based start-up, has just closed its oversubscribed financing round of CHF 1.8 Mio. to start and accelerate...
You must be a Standard 1 Year member to access this content.
Wenger Vieli acted as legal advisor to Basellandschaftliche Kantonalbank. Zurich-based digital financial services provider radicant has received a banking license from the Swiss Financial Market Supervisory...
You must be a Standard 1 Year member to access this content.
